Skip to Content
webinars

Atogepant for the Preventive Treatment of Migraine

Dates:
Oct 30, 2024
Time:
2:00 pm EDT
Presented by Abbvie
Register Now Registration takes place at a third-party website.

About This Webinar

Migraine is a complex, chronic disease that results in significant patient and economic burden. Migraine ranks second worldwide in terms of years lost due to disability. Direct annual all cause health care costs for a person with migraine is over twice that of a person without migraine. Indirect costs from the impact of the disease on a patient’s ability to function (absenteeism and presenteeism) total over $35B annually.

It is important to appropriately manage a person with migraine who experiences greater than 4 attacks a month (or severe disability from at least two attacks a month) and may benefit from preventive therapy. One of the main goals of preventive therapy is to improve function and reduce disability. Utilizing a stratified care approach to preventive migraine treatment is key to accomplish this goal.

Attendees Will Learn About

  • The complexity of migraine disease and the burden of the disease as it relates to function
  • Migraine treatment landscape with a focus on a treatment option for migraine prevention

Presenters

Maureen A. Moriarty, DNP, ANP-BC, FAHS, FAANP

Founder

Moriarty Associates, a Comprehensive Headache Center

Dr. Maureen A. Moriarty, current fellow of The American Headache Society is an adult nurse practitioner who manages headache patients in an ambulatory setting. She cares for people with migraine, cluster, tension type headache, post-traumatic headache, and a variety of atypical facial pains. Prior to opening Moriarty Associates, a Comprehensive Headache Center, she worked at Medstar Georgetown…

Learn more about Maureen A. Moriarty, DNP, ANP-BC, FAHS, FAANP